about
Epirubicin dose and sequential hormonal therapy-Mature results of the HMFEC randomised phase III trial in premenopausal patients with node positive early breast cancer.Can routine data be used to support cancer clinical trials? A historical baseline on which to build: retrospective linkage of data from the TACT (CRUK 01/001) breast cancer trial and the National Cancer Data Repository.NEOCENT: a randomised feasibility and translational study comparing neoadjuvant endocrine therapy with chemotherapy in ER-rich postmenopausal primary breast cancer.ESR1 mutations and overall survival on fulvestrant versus exemestane in advanced hormone receptor positive breast cancer: A combined analysis of the phase III SoFEA and EFECT trials
P50
description
researcher
@en
wetenschapper
@nl
name
Lucy Suzanne Kilburn
@en
Lucy Suzanne Kilburn
@nl
type
label
Lucy Suzanne Kilburn
@en
Lucy Suzanne Kilburn
@nl
prefLabel
Lucy Suzanne Kilburn
@en
Lucy Suzanne Kilburn
@nl
P31
P496
0000-0002-1987-7545